AMY B WECHSLER
CIK 1677300 · last filed 2026-05-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.59M
Companies
2
Total Filings
55
Lifetime Open-Market Net
-$350.8K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BHC | Director | 313,585 | $5.06 | $1.59M | -$350.8K | 40 | 2026-05-26 |
| Damora Therapeutics, Inc. (GLTO) Delisted | Director | — | $28.69 | — | $0 | 2 | 2025-06-20 |
Recent Filings · Page 6 of 6
55 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2017-04-04 | — | Grant (A) | +2,460 | $27.1K | |
| 2017-01-04 | — | Grant (A) | +1,721 | $25.0K | |
| 2016-10-04 | — | Grant (A) | +1,018 | $25.0K | |
| 2016-07-11 | — | Grant (A) | +225 | $4.5K | |
| 2016-06-21 | — | Grant (A) | +16,726 | $0 |
Showing 51–55 of 55
Prev
Page 6 of 6
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.